Hims & Hers signals beyond the news: 36+ signals from 5 sources
The latest Hims & Hers signal on this page is from Nov 17, 2026 (Patents): "Hims, Inc.'s patent output is steady: 1 grant in the past year, 1 in the past 30 days." The busiest sources: LinkedIn (15+), YouTube (12) and Reddit (4).
Privatehims.com
Get Hims & Hers' live signals in Claude or ChatGPT, or by API
What changed at Hims & Hers this week? Use Autobound signals for hims.com.- Signals
- 36+
- Sources
- 5
- Last 90 days
- 16
- Latest
- Nov 17, 2026
Source: Autobound Signal API · 57 signals tracked for Hims & Hers · updated
Other signals · latest 10
Latest Hims & Hers signals by source
36+ signals for Hims & Hers across 5 sources.
Patents · Patent pace
Hims, Inc.'s patent output is steady: 1 grant in the past year, 1 in the past 30 days.
Over the past year Hims, Inc. received 1 US patent grant; the recent pace (1 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 1
- Grants, 90 days
- 1
- Grants, 30 days
- 1
- USPTO assignee
- Hims, Inc.
Patents · Patent grant
Hims was granted a patent for a gummy product design.
In November 2026 Hims received design protection for the appearance of a gummy used in consumer wellness products.
- Grant date
- Nov 10, 2026
- Inventors
- Jakob Tiefenbacher, Maxime Dubreucq
LinkedIn
Hims works with Eli Lilly to expand Zepbound and Foundayo access through unified care.
We’re working with Eli Lilly and Company to expand access to Zepbound and Foundayo. No more switching to third-party platforms, no more split payments. Just one, unified care experience that is simple, straightforward, and personal. Read more, including important info: https://lnkd.in/g3zJcQ3p
- Likes
- 362
- Comments
- 3
- Tags
- Partnership, Pharmaceuticals
- Initiatives
- unified care platform expansion with Lilly
LinkedIn
Hims CEO says the FDA allows compounding of six peptides, Hims plans Peptides+ service.
Yesterday the Department of Health and Human Services moved to allow compounding of six peptides while formal rulemaking is underway, giving people a real alternative to the dangerous gray market so many are already using, often without a clinician involved or knowing what’s actually in the product. This draft...
- Likes
- 320
- Comments
- 9
- Tags
- Regulations, Pharmaceuticals, Healthcare Operations
- Initiatives
- launching Peptides+ specialty service
Podcasts · Tech adoption
Hims House discusses Hims & Hers: tech adoption
"Himes has kind of set their lineup in terms of who's going to be defending them. And they have a national firm, Baker Hostetler, which is a well-known national firm."
- Podcast
- Hims House
- Episode
- 🚨 THE FTC SUES HIMS & HERS -- Full breakdown with Gaston Kroub
- Speaker
- Gaston Kroub
- Speaker role
- Third party
Reddit · Customer feedback
A Hims subscriber is considering leaving the service due to high medication and membership fees and difficulty accessing prescription records in the app.
Post: "Switching from Hims to Rift"
- Subreddit
- r/joinrift
- Upvotes
- 11
- Comments
- 24
- Sentiment
- Negative
Reddit · Customer feedback
A customer canceled their $149/month Hims subscription after criticizing unexpected recurring fees and unhelpful support regarding an early refill request for Wegovy.
Post: "So glad I canceled my $149.00 /month worthless subscription."
- Subreddit
- r/HIMS
- Upvotes
- 0
- Comments
- 2
- Sentiment
- Negative
YouTube
Q2 Regnskaber fra Hims & Hers, Sea LTD og kæmpe NVIDIA nyheder - Mads giver sit take
NewDeal Invest reviews Q2 earnings for Hims & Hers, Sea LTD, and NVIDIA's financial deal.
- Channel
- NewDeal Invest
- Views
- 6
- Comments
- 0
- Tags
- Financial Analysis, Company Earnings, Technology News
Podcasts · Industry prediction
Hims House discusses Hims & Hers: industry prediction
"the industry check suggests for HIMSS and Rho peptides are more of a 2027 story in terms of revenue. Is that right? That's right."
- Podcast
- Hims House
- Episode
- Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share
- Speaker
- Ryan McDonald
- Speaker role
- Third party
YouTube
😱 $HIMS EARNINGS PART 1 - KEY FINANCIAL HIGHLIGHTS #hims #investing #wealth #stockmarket #stocks
Hims Q1 earnings show subscriber growth and raised guidance, but significant margin compression and net losses.
- Channel
- Earn It - Save It - Invest It
- Views
- 101
- Comments
- 0
- Tags
- Earnings Report, Strategic Shift, GLP-1 Medications, Telehealth
Showing 10 of 36+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Hims & Hers with the Signal API
One POST /v1/companies/enrich call with hims.com returns Hims & Hers signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "hims.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Company pages
Related companies
Questions about Hims & Hers other signals
What signals does Autobound track for Hims & Hers besides news and filings?
What are people saying about Hims & Hers online?
Has Hims & Hers been granted patents recently?
Page updated , the date of the newest row on this page.
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .